CME Group Inc
NASDAQ: CME · FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES
Updated 2026-04-29
CME Group Inc (CME) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Price target summary
Management guidance
CME management has not provided specific revenue targets through 2030 in available guidance. CEO Terrence Duffy has emphasized record trading volumes (37.6M ADV in Feb 2026, +14% YoY) and strategic expansion into 24/7 crypto trading and tokenized settlement via partnerships with BMO and Google Cloud. Company is focused on product innovation and market share gains in derivatives rather than disclosing forward revenue guidance.
Revenue & price projection
Financial forecast — research-backed
| Metric | 2023 | 2024 | 2025 | 2026 (E) | 2027 (E) | 2028 (E) |
|---|---|---|---|---|---|---|
| Revenue | $5.6B | $6.1B | $6.5B | $7.1B | $7.4B | $7.8B |
| Revenue growth | — | 9.9% | 6.4% | 8.6% | 4.7% | 5.3% |
| EPS | $9.34 | $10.26 | $11.21 | $12.05 | $12.82 | $13.65 |
| P/S ratio | — | — | — | 12.0x | 12.0x | 12.0x |
| Implied price | — | — | — | $244.09 | $244.09 | $274.60 |
Catalysts & risks
Methodology
CME Group Inc's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 13 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.
WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 6, 2026.